Skip to content

Effect of SNARE complex gene polymorphism on the pharmacodynamics of propofol

Effect of SNARE complex gene polymorphism on the pharmacodynamics of propofol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069550
Enrollment
Unknown
Registered
2023-03-20
Start date
2023-04-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug administration group:Propofol anesthesia induction and awakening

Sponsors

Lianyungang Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2. BMI 18.5~27.9 kg/m2; 3. American Society of Anesthesiologists (ASA) classification: Class I or II.

Exclusion criteria

Exclusion criteria: 1. Propofol component allergy; 2. Chronic alcoholics; 3. Previous history of cerebral infarction; 4. History of severe mental illness; 5. Severe cardiovascular disease; 6. Poorly controlled hypertension, diabetes mellitus; 7. Hyperthyroidism, endocrine dysfunction; 8. Severe hepatic insufficiency, renal insufficiency (creatinine > 186 µmol/L, bilirubin > 20 µmol/L or plasma albumin < 30 g/L); 9. History of long-term sedative-hypnotic drugs, hepatic enzyme inducers or inhibitors taken within one month prior to surgery; 10. Taking drugs that may affect autonomic function, such as atropine, propranolol, mecamylamine, etc.; 11. Preoperative trauma and other stressful conditions exist, such as fracture patients, indwelling gastric tube or urinary catheter, and other operations; 12. Patients who are pregnant, hearing impaired, and unable to cooperate with the experiment.

Design outcomes

Primary

MeasureTime frame
Consciousness state;

Secondary

MeasureTime frame
Bispectral index;Heart rate variability;Heart rate;Arterial blood pressure;Perfusion index;

Countries

China

Contacts

Public ContactJunlong Zhang

Lianyungang Second People's Hospital

zjlddqzyw@126.com+86 157 1513 9688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026